{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:13:30Z","timestamp":1792494810700,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":466,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pathology Informatics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.4103\/jpi.jpi_26_21","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T07:28:50Z","timestamp":1631777330000},"page":"35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Artificial Intelligence in Plasma Cell Myeloma: Neural Networks and Support Vector Machines in the Classification of Plasma Cell Myeloma Data at Diagnosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Ashwini K.","family":"Yenamandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Maris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4103\/jpi.jpi_26_21_bib1","series-title":"Case 411 \u2013 A Solitary Bone Lesion [Internet]","author":"LaCaria","year":"2012"},{"key":"10.4103\/jpi.jpi_26_21_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1200\/JCO.18.02096","article-title":"Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline","volume":"37","author":"Mikhael","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.4103\/jpi.jpi_26_21_bib3","unstructured":"NCCN.org [Internet]. Washington, D.C.: National Comprehensive Cancer Network, c2021 [cited 2020 Apr]. Available from: https:\/\/NCCN.org\/store\/login\/login.aspx?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/myeloma.pdf."},{"key":"10.4103\/jpi.jpi_26_21_bib4","unstructured":"Cancer.org [Internet]. Washington, D.C.: American Cancer Society, c2021 [cited 2020 Apr]. Available from: https:\/\/cancer.org\/cancer\/multiple-myeloma.html."},{"key":"10.4103\/jpi.jpi_26_21_bib5","author":"National Institute of Health (NIH)"},{"key":"10.4103\/jpi.jpi_26_21_bib7","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1182\/blood-2010-10-300970","article-title":"Consensus recommendations for risk stratification in multiple myeloma: Report of the International Myeloma Workshop Consensus Panel 2","volume":"117","author":"Munshi","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.4103\/jpi.jpi_26_21_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamaoncol.2016.3160","article-title":"Association of minimal residual disease with superior survival outcomes in patients with multiple myeloma: A meta-analysis","volume":"3","author":"\u201cMunshi","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.4103\/jpi.jpi_26_21_bib9","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.4103\/jpi.jpi_26_21_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/EDBK_200879","article-title":"Risk stratification and targets in multiple myeloma: From genomics to the bedside","volume":"38","author":"Perrot","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.4103\/jpi.jpi_26_21_bib11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.6004\/jnccn.2015.0167","article-title":"Multiple myeloma, version 2.2016: Clinical practice guidelines in oncology","volume":"13","author":"Anderson","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.4103\/jpi.jpi_26_21_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.4103\/jpi.jpi_26_21_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bmb\/ldu041","article-title":"Genetics in myeloma: Genetic technologies and their application to screening approaches in myeloma","volume":"113","author":"Talley","year":"2015","journal-title":"Br Med Bull"},{"key":"10.4103\/jpi.jpi_26_21_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05058-y","article-title":"Genomic patterns of progression in smoldering multiple myeloma","volume":"9","author":"Bolli","year":"2018","journal-title":"Nat Commun"},{"key":"10.4103\/jpi.jpi_26_21_bib15","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2014-10-567370","article-title":"Genetics of multiple myeloma: Another heterogeneity level?","volume":"125","author":"Corre","year":"2015","journal-title":"Blood"},{"key":"10.4103\/jpi.jpi_26_21_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/leu.2013.199","article-title":"Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms","volume":"28","author":"Walker","year":"2014","journal-title":"Leukemia"},{"key":"10.4103\/jpi.jpi_26_21_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cancergen.2018.07.002","article-title":"Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders","volume":"228-229","author":"Pugh","year":"2018","journal-title":"Cancer Genet"},{"key":"10.4103\/jpi.jpi_26_21_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3343\/alm.2018.38.3.196","article-title":"Clinical utility of a diagnostic approach to detect genetic abnormalities in multiple myeloma: A single institution experience","volume":"38","author":"Jung","year":"2018","journal-title":"Ann Lab Med"},{"key":"10.4103\/jpi.jpi_26_21_bib19","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood-2014-07-587964","article-title":"Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: The IFM experience","volume":"125","author":"Hebraud","year":"2015","journal-title":"Blood"},{"key":"10.4103\/jpi.jpi_26_21_bib20","author":"Keen-Kim"},{"key":"10.4103\/jpi.jpi_26_21_bib21","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.clml.2017.02.018","article-title":"High-risk multiple myeloma: Definition and management","volume":"17S","author":"Joseph","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.4103\/jpi.jpi_26_21_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/jpi.jpi_43_18","article-title":"Artificial intelligence in cytopathology: A neural network to identify papillary carcinoma on thyroid fine-needle aspiration cytology smears","volume":"9","author":"Sanyal","year":"2018","journal-title":"J Pathol Inform"},{"key":"10.4103\/jpi.jpi_26_21_bib23","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","article-title":"Mutational spectrum, copy number changes, and outcome: Results of a sequencing study of patients with newly diagnosed myeloma","volume":"33","author":"Walker","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.4103\/jpi.jpi_26_21_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-44215-1","article-title":"Rapid discrimination of multiple myeloma patients by artificial neural networks coupled with mass spectrometry of peripheral blood plasma","volume":"9","author":"Deulofeu","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.4103\/jpi.jpi_26_21_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/23808993.2017.1380516","article-title":"The role of artificial intelligence in medicine","volume":"2","author":"Mesko","year":"2017","journal-title":"Expert Review of Precision Medicine and Drug Development"},{"key":"10.4103\/jpi.jpi_26_21_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0167-7012(00)00201-3","article-title":"Artificial neural networks: Fundamentals, computing, design, and application","volume":"43","author":"Basheer","year":"2000","journal-title":"J Microbiol Methods"},{"key":"10.4103\/jpi.jpi_26_21_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2478\/v10136-012-0031-x","article-title":"Artificial neural networks in medical diagnosis","volume":"11","author":"Amato","year":"2013","journal-title":"J Appl Biomed"},{"key":"10.4103\/jpi.jpi_26_21_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/14639238809010100","article-title":"Artificial intelligence techniques for cancer treatment planning","volume":"13","author":"Ardizzone","year":"1988","journal-title":"Med Inform (Lond)"},{"key":"10.4103\/jpi.jpi_26_21_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-44215-1","article-title":"Rapid discrimination of multiple myeloma patients by artificial neural networks coupled with mass spectrometry of peripheral blood plasma","volume":"9","author":"Deulofeu","year":"2019","journal-title":"Sci Rep"},{"key":"10.4103\/jpi.jpi_26_21_bib30","unstructured":"Tensorflow.org [Internet]. [cited 2020 Apr]. Available from: https:\/\/tensorflow.org."},{"key":"10.4103\/jpi.jpi_26_21_bib31","unstructured":"Keras.io [Internet]. [cited 2020 Apr]. Available from: https:\/\/keras.io."},{"key":"10.4103\/jpi.jpi_26_21_bib32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.25791","article-title":"Multiple myeloma: 2020 update on diagnosis, risk-stratification and management","volume":"95","author":"Rajkumar","year":"2020","journal-title":"Am J Hematol"}],"container-title":["Journal of Pathology Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2153353922001572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2153353922001572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:44:25Z","timestamp":1761871465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2153353922001572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2153353922001572"],"URL":"https:\/\/doi.org\/10.4103\/jpi.jpi_26_21","relation":{},"ISSN":["2153-3539"],"issn-type":[{"value":"2153-3539","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial Intelligence in Plasma Cell Myeloma: Neural Networks and Support Vector Machines in the Classification of Plasma Cell Myeloma Data at Diagnosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pathology Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4103\/jpi.jpi_26_21","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 THE AUTHORS. Published by Elsevier Inc on behalf of the Association for Pathology Informatics","name":"copyright","label":"Copyright"}],"article-number":"35"}}